5 researchers will share a $500,000 medical prize for his or her roles in creating a groundbreaking, gene-modifying device that lets scientists alter the DNA of dwelling cells.
The recipients of the Albany Medical Middle Prize in Drugs and Biomedical Analysis introduced Tuesday are being acknowledged for his or her accomplishments associated to the event of the software, referred to as CRISPR-Cas9. The quicker, cheaper and easier software has sparked a growth in analysis over the previous 5 years.
The recipients are: Emmanuelle Charpentier of the Max Planck Institute for An infection Biology, Germany; Jennifer Doudna, College of California, Berkeley; Luciano Marraffini, The Rockefeller College, New York Metropolis; Francisco J.M. Mojica, College of Alicante, Spain; Feng Zhang, Massachusetts Institute of Know-how, Cambridge, Massachusetts.
They may obtain the award at a ceremony Sept. 27 in Albany, New York.